These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8891915)

  • 81. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.
    Thompson WC; Dasgupta A
    Clin Chem; 1994 Sep; 40(9):1703-6. PubMed ID: 7915216
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs.
    Garofano L; Santoro M; Patri P; Guidugli F; Bollani T; Favretto D; Traldi P
    Rapid Commun Mass Spectrom; 1998; 12(12):779-82. PubMed ID: 9650303
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rapid screening method for determination of Ecstasy and amphetamines in urine samples using gas chromatography-chemical ionisation mass spectrometry.
    Pellegrini M; Rosati F; Pacifici R; Zuccaro R; Romolo FS; Lopez A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):243-51. PubMed ID: 11996490
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Bork WR; Maurer HH
    J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
    Yeh SY; Hsu FL
    Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The prevalence of MDMA/MDA in both hair and urine in drug users.
    Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H
    Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 91. New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Staack RF; Maurer HH
    J Mass Spectrom; 2004 Mar; 39(3):255-61. PubMed ID: 15039932
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Nervenarzt; 1996 May; 67(5):369-80. PubMed ID: 9005345
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The designer drug situation in Ibiza.
    Lora-Tamayo C; Tena T; Rodríguez A; Moreno D; Sancho JR; Enseñat P; Muela F
    Forensic Sci Int; 2004 Mar; 140(2-3):195-206. PubMed ID: 15036441
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
    Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
    Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2009 Jun; 37(6):1152-6. PubMed ID: 19299523
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.
    Staack RF; Fehn J; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):27-41. PubMed ID: 12726841
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives.
    Kraemer T; Maurer HH
    Ther Drug Monit; 2002 Apr; 24(2):277-89. PubMed ID: 11897973
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry.
    Springer D; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 793(2):377-88. PubMed ID: 12906913
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry.
    Springer D; Peters FT; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):25-33. PubMed ID: 12015267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.